Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $19.65 $24.19 Monday, 13th May 2024 PRTA stock ended at $20.71. This is 2.95% less than the trading day before Friday, 10th May 2024. During the day the stock fluctuated 5.72% from a day low at $20.65 to a day high of $21.83.
90 days $19.65 $31.01
52 weeks $19.65 $77.11

Historical Prothena Corporation plc prices

Date Open High Low Close Volume
Jun 21, 2023 $69.75 $71.16 $68.68 $69.80 279 713
Jun 20, 2023 $68.04 $70.84 $67.42 $70.18 356 287
Jun 16, 2023 $74.00 $74.43 $68.07 $68.43 1 020 666
Jun 15, 2023 $71.65 $72.66 $70.52 $72.57 357 787
Jun 14, 2023 $76.20 $76.20 $71.39 $71.85 422 483
Jun 13, 2023 $73.22 $77.11 $73.22 $76.43 707 047
Jun 12, 2023 $70.24 $73.11 $70.21 $73.01 565 801
Jun 09, 2023 $69.95 $70.60 $68.72 $69.50 280 999
Jun 08, 2023 $71.82 $72.17 $69.85 $69.95 299 693
Jun 07, 2023 $72.19 $72.94 $69.42 $72.29 473 783
Jun 06, 2023 $69.47 $72.09 $68.50 $72.01 296 885
Jun 05, 2023 $68.66 $70.87 $68.52 $69.26 330 169
Jun 02, 2023 $66.97 $69.08 $66.37 $69.01 414 666
Jun 01, 2023 $66.44 $67.97 $64.86 $66.39 224 572
May 31, 2023 $64.90 $67.06 $63.52 $66.43 597 339
May 30, 2023 $66.13 $66.90 $64.02 $64.51 370 969
May 26, 2023 $66.75 $68.16 $65.54 $66.44 385 011
May 25, 2023 $69.78 $69.95 $66.83 $67.25 367 715
May 24, 2023 $70.09 $71.24 $68.92 $69.63 338 351
May 23, 2023 $72.82 $74.14 $70.25 $70.56 445 286
May 22, 2023 $74.01 $74.99 $72.69 $72.80 422 898
May 19, 2023 $74.60 $74.97 $73.03 $73.82 371 158
May 18, 2023 $75.84 $75.84 $72.90 $73.64 375 960
May 17, 2023 $74.99 $76.08 $72.12 $76.00 637 700
May 16, 2023 $73.39 $74.83 $70.83 $73.25 583 915
Click to get the best stock tips daily for free!

About Prothena Corporation plc

Prothena  plc Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a humanized monoclonal antibody, which is in Phase IIb clinical trial for the treatment of Parkinson's disease... PRTA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT